Board of Directors

About

The board of directors at Asher Biotherapeutics has a wide range of experience in the medical and biotech industries. Some of their previous experiences include being a partner at Third Rock Ventures, executive chairman of the board at Delinia, member of the board of directors at Nora Therapeutics, vice president of corporate and product development at Infinity Pharmaceuticals, and director of precision immunology institute ISMMS at Icahn School of Medicine at Mount Sinai. They also have experience as a full professor at Washington University in St. Louis, Andrew M and Jane M Bursky Professor of Pathololgy and Immunology at Washington University in Saint Louis, and Andrew M. and Jane M. Bursky Distinguished Professor at Washington University in Saint Louis. Additionally, they have been vice president at Vion Pharmaceuticals and head of biologics evaluation section Investigational Drug Branch CTEP at National Cancer Institute (NCI). The board of directors' education histories include Stanford University School of Medicine in Immunology, University of Algeria in Medicine, Washington University School of Medicine in St. Louis in Molecular Genetics/Biochemistry, Murray State University in Molecular Genetics/Biochemistry, State University of New York at Buffalo in Chemistry, State University of New York at Buffalo - School of Medicine & Biomedical Sciences in Biochemistry and Immunology, and Rice University in Biochemistry.